Free Trial

Danske Bank A S Sells 881,301 Shares of UiPath, Inc. $PATH

UiPath logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Danske Bank A/S sold 881,301 UiPath shares in Q4, cutting its stake by 83.5% and leaving 173,580 shares worth about $2.85 million.
  • Analysts are mixed: Morgan Stanley recently upgraded UiPath to "positive," but the consensus remains a Hold with an average price target of $14.07 (3 Buys, 14 Holds, 1 Sell).
  • UiPath's latest quarter beat estimates — $0.30 EPS vs. $0.25 expected and revenue of $481.11M (up 13.4% YoY) — with a market cap around $5.61 billion and a 52-week range of $9.28–$19.84.
  • Five stocks we like better than UiPath.

Danske Bank A S cut its stake in shares of UiPath, Inc. (NYSE:PATH - Free Report) by 83.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 173,580 shares of the company's stock after selling 881,301 shares during the period. Danske Bank A S's holdings in UiPath were worth $2,845,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of PATH. Noble Wealth Management PBC purchased a new stake in UiPath in the 4th quarter worth approximately $25,000. Raleigh Capital Management Inc. bought a new position in shares of UiPath in the fourth quarter worth $26,000. TD Waterhouse Canada Inc. raised its position in shares of UiPath by 1,270.8% in the fourth quarter. TD Waterhouse Canada Inc. now owns 1,782 shares of the company's stock worth $29,000 after buying an additional 1,652 shares in the last quarter. CoreCap Advisors LLC boosted its stake in UiPath by 92.3% during the fourth quarter. CoreCap Advisors LLC now owns 2,579 shares of the company's stock valued at $42,000 after buying an additional 1,238 shares during the period. Finally, GAMMA Investing LLC boosted its stake in UiPath by 93.3% during the fourth quarter. GAMMA Investing LLC now owns 5,251 shares of the company's stock valued at $86,000 after buying an additional 2,534 shares during the period. 62.50% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

PATH has been the topic of a number of research analyst reports. Morgan Stanley upgraded UiPath from an "equal weight" rating to a "positive" rating in a research note on Friday, March 13th. Weiss Ratings reissued a "hold (c)" rating on shares of UiPath in a report on Friday, March 27th. Royal Bank Of Canada set a $14.00 target price on shares of UiPath in a research note on Wednesday, February 11th. Bank of America cut their price target on shares of UiPath from $14.00 to $12.00 and set an "underperform" rating for the company in a research note on Thursday, March 12th. Finally, Wells Fargo & Company decreased their price target on shares of UiPath from $14.00 to $13.00 and set an "equal weight" rating on the stock in a report on Thursday, March 12th. Three analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $14.07.

Check Out Our Latest Stock Report on PATH

UiPath Price Performance

Shares of NYSE:PATH opened at $10.71 on Wednesday. The company's fifty day moving average price is $10.94 and its 200-day moving average price is $13.51. The firm has a market capitalization of $5.61 billion, a price-to-earnings ratio of 20.59, a PEG ratio of 1.77 and a beta of 0.91. UiPath, Inc. has a one year low of $9.28 and a one year high of $19.84.

UiPath (NYSE:PATH - Get Free Report) last issued its quarterly earnings results on Wednesday, March 11th. The company reported $0.30 EPS for the quarter, topping analysts' consensus estimates of $0.25 by $0.05. UiPath had a net margin of 17.53% and a return on equity of 5.69%. The firm had revenue of $481.11 million for the quarter, compared to analyst estimates of $464.81 million. During the same quarter in the prior year, the firm earned $0.26 EPS. The business's revenue for the quarter was up 13.4% compared to the same quarter last year. As a group, equities research analysts expect that UiPath, Inc. will post 0.32 EPS for the current year.

UiPath Profile

(Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.

See Also

Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath, Inc. (NYSE:PATH - Free Report).

Institutional Ownership by Quarter for UiPath (NYSE:PATH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UiPath Right Now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines